Azenta (AZTA)
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, t...
- Open
- 33.320
- High
- 34.310
- Low
- 31.860
- Prev. Close
- 37.400
- Volume
- 1.90M
- Turnover
- 63.53M
- Avg Price
- 33.513
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 6.55%
- 52wk High
- 41.730
- Volume Ratio
- 2.68
- Turnover Ratio
- 4.94%
Azenta Analyst Rating
View moreForecast & Rating
Aug 6, 2026Price forecast
$34.805.84%
Forecast & RatingBuy
6analysts
- Strong buy33.33%
- Buy16.67%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- Top Gainers&Losers · 1 hour ago
Top 10 US Stock Losers (8.24)
- StockTitan · 19 hours ago
AZENTA ANNOUNCES LEADERSHIP TRANSITION | CG Stock News
- Quartr · Aug 5 at 07:17 AM
AZTA: Q3 2026 saw 12% revenue growth, margin pressure, and raised FY2026 guidance
- Tip Ranks · Aug 4 at 06:05 PM
Azenta: Buy Rating Reaffirmed as Strong Q3 Trends Support Outlook; $33 Price Target Maintained
- PUBT · Aug 4 at 05:18 PM
Azenta SVP, General Counsel and Secretary Ephraim Starr acquires 335 common shares valued at $8,095.15
- Market Beat · Aug 4 at 04:56 PM
Azenta (NASDAQ:AZTA) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPS
